5-Star Stocks Poised to Pop: Stryker (SYK)

5-Star Stocks Poised to Pop: Stryker

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, orthopedic devices giant Stryker (NYSE: SYK ) has earned a coveted five-star ranking.

With that in mind, let's take a closer look at Stryker's business and see what CAPS investors are saying about the stock right now.

Stryker facts

Headquarters (founded)	Kalamazoo, Mich. (1941)
Market Cap	$19.8 billion
Industry	Health care equipment
Trailing-12-Month Revenue	$8.5 billion
Management	Interim CEO/CFO Curt Hartman Vice President Curtis Hall
Return on Equity (average, past 3 years)	17.8%
Cash/Debt	$3.5 billion / $1.8 billion
Dividend Yield	1.6%
Competitors	Biomet Johnson & Johnson Zimmer Holdings

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 98% of the 1,483 members who have rated Stryker believe the stock will outperform the S&P 500 going forward.

Just last month, one of those bulls, valuemoneygreen, succinctly summed up the bull case for our community:

Stryker is like my #1 pick for the medical products industry. This company has made money forever and will no doubt in my mind continue to do so. ... 10% growth over the next 5 years. Return on capital of 16% on average over the last five years. Don't stop there look at the last 20. ... Long history and a good track record in the health care industry.

If you want market-topping returns, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite its five-star rating, Stryker may not be your top choice.

If that's the case, we've compiled a special free report for investors called "The 3 Dow Stocks Dividend Investors Need," which uncovers a few other juicy income opportunities. The report is 100% free, but it won't be around forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. The Motley Fool owns shares of Johnson & Johnson and Zimmer Holdings. Motley Fool newsletter services have recommended buying shares of Johnson & Johnson and Stryker. Motley Fool newsletter services have also recommended creating a diagonal call position in Johnson & Johnson. The Motley Fool has a disclosure policy.
We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.